Keros Therapeutics, Inc.
(NASDAQ : KROS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.06%171.110.7%$969.22m
ABBVAbbVie, Inc. 0.23%138.361.9%$829.91m
PFEPfizer Inc. 0.24%49.390.9%$827.10m
LLYEli Lilly & Co. -0.25%300.551.1%$744.28m
MRKMerck & Co., Inc. -0.16%87.270.7%$738.70m
BMYBristol-Myers Squibb Co. 0.04%72.151.0%$650.09m
SIGASIGA Technologies, Inc. 3.22%24.050.0%$426.14m
AZNAstraZeneca Plc -0.30%65.831.0%$380.31m
ALNYAlnylam Pharmaceuticals, Inc. 0.64%219.978.1%$242.80m
GSKGSK Plc 0.00%40.570.3%$217.86m
HZNPHorizon Therapeutics Plc 0.04%69.635.4%$197.87m
SGENSeagen Inc. 1.61%178.645.7%$191.78m
NVSNovartis AG 0.50%86.000.2%$174.26m
RGENRepligen Corp. 0.06%246.416.7%$155.84m
NVONovo Nordisk A/S -0.59%102.590.1%$151.99m

Company Profile

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.